216 completed, 32 terminated, 18 unknown, 17 recruiting. 298 Phase 3, 55 Phase 2.
Follow Parkinsonian Disorders: new trials by email Literature Review of Parkinsonian Disorders trials Research Report on Parkinsonian Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P) ONO-2808, Placebo - Multiple System Atrophy, Parkinson Variant | Phase 3 | Not yet recruiting | Ono Pharmaceutical Co., Ltd. | 486 | 2027-01-01 | 2026-09-17 |
| Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians Injection of Dysport then placebo, Injection of placebo then Dysport - PARKINSON DISEASE (Disorder) | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 39 | 2026-12-01 | 2026-11-04 |
| Phase â…˘ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease TJ0113 200mg, TJ0113 400mg, Placebo - Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset | Phase 3 | Recruiting | Hangzhou PhecdaMed Co., Ltd. | 300 | 2026-11-05 | 2026-11-18 |
| VG081821AC Tablets for Early to Mid-stage Parkinson's Disease VG081821AC, Placebo - Parkinson Disease (PD) | Phase 2 / Phase 3 | Recruiting | Zhejiang Vimgreen Pharmaceuticals, Ltd. | 152 | 2026-07-17 | 2026-09-03 |
| Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations Safinamide, Placebo - PARKINSON DISEASE (Disorder), Pain | Phase 3 | Recruiting | Universita di Verona | 60 | 2026-04-28 | 2026-08-13 |
| Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Parkinson's Disease Transcranial Direct Current Stimulation - PARKINSON DISEASE (Disorder), Parkinson Disease | Phase 3 | Not yet recruiting | Dr. Ram Manohar Lohia Hospital | 30 | 2026-02-01 | 2026-02-09 |
| A Study of Buntanetap in Participants With PD buntanetap/posiphen - Parkinson's Disease (PD), Deep Brain Stimulation | Phase 2 / Phase 3 | Recruiting | Annovis Bio Inc. | 500 | 2026-01-09 | 2026-10-30 |
| Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach Atomoxetine, Placebo - Parkinson's Disease (PD), Freezing of Gait | Phase 3 | Recruiting | Radboud University Medical Center | 60 | 2026-01-01 | 2026-02-27 |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease Prasinezumab, Placebo - Parkinson's Disease | Phase 3 | Recruiting | Hoffmann-La Roche | 900 | 2025-11-24 | 2026-11-05 |
| Metformin in Parkinson Disease Levodopa Carbidopa, Metformin - Parkinson Disease | Phase 2 / Phase 3 | Recruiting | Tanta University | 60 | 2025-11-10 | 2025-11-21 |
| Vinpocetine in Patients With Parkinsonian Disease Levodopa Carbidopa, Vinpocetine - Parkinson Disease | Phase 2 / Phase 3 | Recruiting | Tanta University | 60 | 2025-11-10 | 2025-12-10 |
| Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease LECIG (levodopa, carbidopa, entacapone intestinal gel), Best oral medication - PARKINSON DISEASE (Disorder) | Phase 3 | Recruiting | University Hospital Tuebingen | 150 | 2025-10-27 | 2026-07-13 |
| Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial Placebo, Telmisartan, Terazosin (Hytrin) - Parkinsons Disease (PD) | Phase 3 | Recruiting | University College, London | 1200 | 2025-09-12 | 2025-10-03 |
| A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease bemdaneprocel, Sham surgery - Parkinsons Disease (PD) | Phase 3 | Recruiting | BlueRock Therapeutics | 102 | 2025-06-17 | 2026-11-02 |
| A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease BHV-8000 10mg, BHV-8000 20 mg, Placebo - Parkinson Disease | Phase 2 / Phase 3 | Recruiting | Biohaven Therapeutics Ltd. | 550 | 2025-05-28 | 2026-10-22 |
| A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's Aria Sensor - Dysphagia, Parkinson Disease | Phase 3 | Completed | Northwestern University | 59 | 2025-04-01 | 2026-11-05 |
| Ambroxol to Slow Progression in Parkinson Disease Ambroxol Hydrochloride (420mg), Placebo - Parkinson Disease | Phase 3 | Recruiting | University College, London | 330 | 2025-02-25 | 2025-05-01 |
| Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients Metformin, placebo - Parkinson Disease | Phase 3 | Active not recruiting | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 74 | 2024-12-29 | 2025-07-09 |
| Fexofenadine as Adjuvant Therapy in Parkinson Disease Levodopa/carbidopa, Fexofenadine - Parkinson Disease | Phase 2 / Phase 3 | Recruiting | Tanta University | 46 | 2024-12-10 | 2026-01-21 |
| A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations HRG2010; Sustained-release Carbidopa/Levodopa administered placebo, Sustained-release Carbidopa/Levodopa; HRG2010 placebo - Parkinson's Disease | Phase 3 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 165 | 2024-11-06 | 2026-11-16 |
Showing 20 of 298. Sign in to see all of them.
Parkinson Disease (289) · Dyskinesias (24) · Lewy Body Disease (10) · Dementia (9) · Movement Disorders (7) · Neurodegenerative Diseases (6) · Alzheimer Disease (5) · Brain Diseases (5) · Central Nervous System Diseases (5) · Essential Tremor (5) · Nervous System Diseases (5) · Deglutition Disorders (4) · Depression (4) · Dizziness (4)
Basal Ganglia Diseases (297) · Synucleinopathies (295) · Brain Diseases (293) · Central Nervous System Diseases (293) · Nervous System Diseases (293) · Movement Disorders (291) · Neurodegenerative Diseases (291) · Pathological Conditions, Signs and Symptoms (44) · Signs and Symptoms (44) · Neurologic Manifestations (39) · Mental Disorders (22) · Neurocognitive Disorders (14) · Cardiovascular Diseases (12) · Vascular Diseases (12)
Pramipexole (17) · carbidopa, levodopa drug combination (17) · rasagiline (17) · Levodopa (16) · rotigotine (14) · istradefylline (11) · Apomorphine (10) · safinamide (10) · ropinirole (9) · pardoprunox (6) · Carbidopa (5) · perampanel (5) · 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine (4) · Tablets (4) · Amantadine (3)
UCB Pharma (15) · Boehringer Ingelheim (11) · AbbVie (10) · GlaxoSmithKline (9) · Kyowa Kirin Co., Ltd. (8) · Newron Pharmaceuticals SPA (8) · Impax Laboratories, LLC (7) · Solvay Pharmaceuticals (7) · Adamas Pharmaceuticals, Inc. (6) · Teva Branded Pharmaceutical Products R&D, Inc. (6) · Kyowa Kirin, Inc. (5) · Radboud University Medical Center (5) · Merck Sharp & Dohme LLC (4) · Mylan Bertek Pharmaceuticals (4) · Otsuka Pharmaceutical Co., Ltd. (4)
United States (142) · Germany (62) · Canada (54) · Spain (51) · France (50) · Italy (45) · United Kingdom (44) · Poland (39) · Czechia (29) · Ukraine (26) · Australia (24) · Israel (24) · Austria (23) · China (22) · Hungary (21)
Neil Sussman, MD (4) · Phyllis Salzman, Ph.D. (4) · Will Sullivan (4) · Charles Oh, MD (3) · David Squillacote, M.D. (3)
PMID 36602886, PMID 38588457, PMID 19126811, PMID 20519680, PMID 21542016, PMID 23667214, PMID 25185211, PMID 26523919, PMID 26882318, PMID 29532440, PMID 30425824, PMID 33864229, PMID 34024025, PMID 36865634, PMID 38070039, PMID 41045349, PMID 41626017, PMID 42475649, PMID 14676468, PMID 14718694, PMID 16216957, PMID 16381181, PMID 16943402, PMID 17052655, PMID 17502459, PMID 17509486, PMID 17881719, PMID 17895872, PMID 18175337, PMID 18378947, PMID 18413464, PMID 18538636, PMID 19058133, PMID 19454631, PMID 19776408, PMID 19959398, PMID 20008998, PMID 20582993, PMID 20589868, PMID 20723221, PMID 20830819, PMID 20937936, PMID 21080009, PMID 21322021, PMID 21482191, PMID 21733529, PMID 21790503, PMID 21831297, PMID 21887710, PMID 22170276
2019 (8), 2004 (5), 2018 (5), 2009 (4), 2025 (4), 2008 (3), 2016 (3), 2005 (2), 2014 (1), 2015 (1), 2017 (1), R01AT000941 (1), U01DC003206 (1), U01NS043128 (1), U01NS050573 (1)